Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00209079Phase 2Terminated
A Phase 2 trial of imatinib in gastric adenocarcinoma, sponsored by Emory University. Started Sep 2004; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00209079.